Eleven Sisters Healthcare Limited 28/02/2025 iXBRL

Company registration number: 10595798

Eleven Sisters Healthcare Limited

Unaudited filleted financial statements

28 February 2025

Eleven Sisters Healthcare Limited

Contents

Directors and other information

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Eleven Sisters Healthcare Limited

Directors and other information


	Directors
		Mrs Esther Erikefe Mensah


	Secretary	Mensah, Esther Erikefe


	Company number	10595798


	Registered office	Nelson Business Centre
		80-82 Nelson Street
		Whitechapel, London
		London, United Kingdom
		E1 2DY


	Accountant	S O A Associates & Co.
		The Link 49 Effra Road
		London
		SW2 1BZ
		United Kingdon




	Bankers	Metro Bank Plc
		One, Southampton Row
		London
		England
		WC1B 5HA

Eleven Sisters Healthcare Limited

Statement of financial position

28 February 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Tangible assets	5	42,958		48,492
		_______		_______
			42,958		48,492

Current assets
Debtors	6	887,644		824,891
Cash at bank and in hand		133,179		54,137
		_______		_______
		1,020,823		879,028
Creditors: amounts falling due
within one year	7	( 648,022)		( 578,730)
		_______		_______
Net current assets			372,801		300,298
			_______		_______
Total assets less current liabilities			415,759		348,790

Creditors: amounts falling due
after more than one year	8		( 11,844)		( 22,492)
			_______		_______
Net assets			403,915		326,298
			_______		_______

Capital and reserves
Called up share capital			100		100
Revaluation reserve			-		16,610
Profit and loss account			403,815		309,588
			_______		_______
Shareholder funds			403,915		326,298
			_______		_______

For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 27 November 2025 , and are signed on behalf of the board by:

Mrs Esther Erikefe Mensah

Director

Company registration number: 10595798

Eleven Sisters Healthcare Limited

Statement of changes in equity

Year ended 28 February 2025

	Called up share capital	Revaluation reserve	Profit and loss account	Total
	£	£	£	£


At 28 February 2023	100	16,610	291,923	308,633

Profit for the year			17,665	17,665
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	17,665	17,665

	_______	_______	_______	_______
At 28 February 2024 and 29 February 2024	100	-	309,588	309,688

Profit for the year			94,227	94,227
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	94,227	94,227

	_______	_______	_______	_______
At 28 February 2025	100	-	403,815	403,915
	_______	_______	_______	_______

Eleven Sisters Healthcare Limited

Notes to the financial statements

Year ended 28 February 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Nelson Business Centre, 80-82 Nelson Street, Whitechapel, London, London, United Kingdom, E1 2DY.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

4. Staff costs

The average number of persons employed by the company during the year amounted to Nil (2024: 126 ).

The aggregate payroll costs incurred during the year were:

	2025	2024
	£	£
Wages and salaries	2,133,214	1,891,481
Social security costs	163,521	-
	_______	_______
	2,296,735	1,891,481
	_______	_______

5. Tangible assets

	Plant and machinery	Fixtures, fittings and equipment	Total
	£	£	£
Cost
At 29 February 2024	30,522	49,284	79,806
Additions	-	3,407	3,407
	_______	_______	_______
At 28 February 2025	30,522	52,691	83,213
	_______	_______	_______
Depreciation
At 29 February 2024	16,943	14,370	31,313
Charge for the year	3,732	5,210	8,942
	_______	_______	_______
At 28 February 2025	20,675	19,580	40,255
	_______	_______	_______
Carrying amount
At 28 February 2025	9,847	33,111	42,958
	_______	_______	_______
At 28 February 2024	13,579	34,914	48,493
	_______	_______	_______

6. Debtors

	2025	2024
	£	£
Trade debtors	887,644	824,891
	_______	_______

7. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	56,417	113,150
Amounts owed to group undertakings and undertakings in which the company has a participating interest	-	108,683
Corporation tax	32,753	31,893
Other creditors	558,852	325,004
	_______	_______
	648,022	578,730
	_______	_______

8. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Bank loans and overdrafts	11,844	22,492
	_______	_______

9. Directors advances, credits and guarantees

Eleven Sisters Healthcare Limited

The following pages do not form part of the statutory accounts.

Eleven Sisters Healthcare Limited

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Eleven Sisters Healthcare Limited

Year ended 28 February 2025

As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 28 February 2025 which comprise the statement of financial position, statement of changes in equity and related notes.

You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.

S O A Associates & Co.

The Link 49 Effra Road

London

SW2 1BZ

United Kingdon

27 November 2025